Katrin Meissl

2.3k total citations · 1 hit paper
21 papers, 1.7k citations indexed

About

Katrin Meissl is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Katrin Meissl has authored 21 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in Katrin Meissl's work include Immune Cell Function and Interaction (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Melanoma and MAPK Pathways (5 papers). Katrin Meissl is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Melanoma and MAPK Pathways (5 papers). Katrin Meissl collaborates with scholars based in Austria, United Kingdom and Netherlands. Katrin Meissl's co-authors include Manuela Baccarini, Daniela Piazzolla, Daniel S. Peeper, Birgit Strobl, Mathias Müller, Sabine Macho‐Maschler, Lucia Kučerová, Sjoerd H. van der Burg, Joanna Kaplon and Els M.E. Verdegaal and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Katrin Meissl

20 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

2013 477 citations Joanna Kaplon, Liang Zheng et al. Nature profile →

Peers

Countries citing papers authored by Katrin Meissl

Since Specialization

Citations

This map shows the geographic impact of Katrin Meissl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Meissl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Meissl more than expected).

Fields of papers citing papers by Katrin Meissl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Meissl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Meissl. The network helps show where Katrin Meissl may publish in the future.

Co-authorship network of co-authors of Katrin Meissl

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Meissl. A scholar is included among the top collaborators of Katrin Meissl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Meissl. Katrin Meissl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cell-type-specific requirement for TYK2 in murine immune cells under steady state and challenged conditions 2025 ·Cellular and Molecular Life Sciences ·(unknown), Agnieszka Witalisz‐Siepracka, Michaela Prchal‐Murphy, David Martin, Felix Sternberg, (unknown), Marlies Dolezal, Nikolaus Fortelny, Matthias Farlik, Sabine Macho‐Maschler, Caroline Lassnig, Katrin Meissl, (unknown), (unknown), Elena E. Pohl, Dagmar Gotthardt, Christoph Bock, Thomas Decker, Birgit Strobl, Mathias Müller	0
2	Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade 2022 ·Haematologica ·(unknown), Sabine Macho‐Maschler, Dorette S. van Ingen Schenau, Miriam Butler, Caroline Lassnig, (unknown), (unknown), Katrin Meissl, Barbara Maurer, (unknown), Claus Vogl, Anna Koren, Stefan Kubicek, Anna Orlova, Richard Moriggl, Birgit Strobl, Veronika Sexl, Frank N. van Leeuwen, Roland P. Kuiper, Mathias Mueller	2
3	T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells 2021 ·Frontiers in Immunology ·(unknown), Katrin Meissl, (unknown), Jonathan W. Lo, Joana F. Neves, Jane K. Howard, Helena Helmby, Nick Powell, Birgit Strobl, Graham M. Lord	12
4	Sustained Post-Developmental T-Bet Expression Is Critical for the Maintenance of Type One Innate Lymphoid Cells In Vivo 2021 ·Frontiers in Immunology ·(unknown), Luke B. Roberts, Katrin Meissl, Jonathan W. Lo, (unknown), Kelly S. Hayes, Tomasz Zabinski, Emily Read, (unknown), (unknown), Jane K. Howard, Richard K. Grencis, Joana F. Neves, Birgit Strobl, Graham M. Lord	14
5	STAT1 Isoforms Differentially Regulate NK Cell Maturation and Anti-tumor Activity 2020 ·Frontiers in Immunology ·Katrin Meissl, (unknown), (unknown), Agnieszka Witalisz‐Siepracka, Klara R. Klein, Caroline Lassnig, (unknown), Claus Vogl, (unknown), Markus Bosmann, Alexander Dohnal, Veronika Sexl, Mathias Müller, Birgit Strobl	20
6	Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation 2019 ·Journal of Molecular Medicine ·Eva Zebedin-Brandl, Madeleine Themanns, Zahra Kazemi, (unknown), Marion Mußbacher, Elizabeth Heyes, Katrin Meissl, Michaela Prchal‐Murphy, W. L. Strohmaíer, (unknown), Michael Freissmuth	2
7	NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity 2019 ·The Journal of Immunology ·(unknown), Agnieszka Witalisz‐Siepracka, Katrin Meissl, Caroline Lassnig, Ursula Reichart, Thomas Kolbe, Matthias Farlik, Christoph Bock, Veronika Sexl, Mathias Müller, Birgit Strobl	15
8	The C-Terminal Transactivation Domain of STAT1 Has a Gene-Specific Role in Transactivation and Cofactor Recruitment 2018 ·Frontiers in Immunology ·(unknown), Katrin Meissl, (unknown), (unknown), (unknown), Sebastian Wienerroither, Pavel Kovarik, Thomas Decker, Mathias Müller, Birgit Strobl	14
9	The good and the bad faces of STAT1 in solid tumours 2015 ·Cytokine ·Katrin Meissl, Sabine Macho‐Maschler, Mathias Müller, Birgit Strobl	193
10	In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity 2015 ·OncoImmunology ·Michaela Prchal‐Murphy, Agnieszka Witalisz‐Siepracka, (unknown), Eva Maria Putz, Dagmar Gotthardt, Katrin Meissl, Veronika Sexl, Mathias Müller, Birgit Strobl	29
11	Near‐genomewide RNA i screening for regulators of BRAF ^V ^600E ‐induced senescence identifies RASEF , a gene epigenetically silenced in melanoma 2014 ·Pigment Cell & Melanoma Research ·Joanna Kaplon, Hömig-Hölzel Cornelia, (unknown), Katrin Meissl, Els M.E. Verdegaal, Sjoerd H. van der Burg, Remco van Doorn, Daniel S. Peeper	13
12	A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence breakdown → 2013 ·Nature ·Joanna Kaplon, Liang Zheng, Katrin Meissl, Barbara Chaneton, Vitaly A. Selivanov, Gillian Mackay, Sjoerd H. van der Burg, Els M.E. Verdegaal, Marta Cascante, Tomer Shlomi, Eyal Gottlieb, Daniel S. Peeper	477
13	Abrogation of BRAF^V600E-induced senescence by PI3K pathway activation contributes to melanomagenesis 2012 ·Genes & Development ·Liesbeth C.W. Vredeveld, Patrícia A. Possik, Marjon A. Smit, Katrin Meissl, Chrysiis Michaloglou, Hugo M. Horlings, (unknown), (unknown), David Dankort, Martin McMahon, Wolter J. Mooi, Daniel S. Peeper	202
14	Evidence of oncogene-induced senescence in thyroid carcinogenesis 2011 ·Endocrine Related Cancer ·Maria Grazia Vizioli, Patrícia A. Possik, Eva Tarantino, Katrin Meissl, Maria Grazia Borrello, Claudia Miranda, Maria Chiara Anania, Sonia Pagliardini, Ettore Seregni, Marco A. Pierotti, Silvana Pilotti, Daniel S. Peeper, Angela Greco	43
15	Raf-1 Addiction in Ras-Induced Skin Carcinogenesis 2009 ·Cancer Cell ·Karin Ehrenreiter, Florian Kern, (unknown), Katrin Meissl, Gergana Galabova‐Kovacs, Maria Sibilia, Manuela Baccarini	86
16	From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-alpha kinase activity 2009 ·Théodora Niault, (unknown), Katrin Meissl, Gregory Weitsman, Daniela Piazzolla, Gabriele D. Maurer, Florian Kern, Karin Ehrenreiter, (unknown), Ismail Moarefi, Thomas Leung, Oliviero Carugo, Tony Ng, Manuela Baccarini	2
17	From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-α kinase activity 2009 ·The Journal of Cell Biology ·Théodora Niault, (unknown), Katrin Meissl, Gregory Weitsman, Daniela Piazzolla, Gabriele D. Maurer, Florian Kern, Karin Ehrenreiter, (unknown), Ismail Moarefi, Thomas Leung, Oliviero Carugo, Tony Ng, Manuela Baccarini	42
18	RASSF1A Elicits Apoptosis through an MST2 Pathway Directing Proapoptotic Transcription by the p73 Tumor Suppressor Protein 2007 ·Molecular Cell ·David Matallanas, David Romano, Karen S. Yee, Katrin Meissl, Lucia Kučerová, Daniela Piazzolla, Manuela Baccarini, J. Keith Vass, Walter Kölch, Eric O’Neill	331
19	Essential role of B-Raf in ERK activation during extraembryonic development 2006 ·Proceedings of the National Academy of Sciences ·Gergana Galabova‐Kovacs, (unknown), Daniela Piazzolla, Katrin Meissl, (unknown), (unknown), Alcino J. Silva, Manuela Baccarini	78
20	Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling 2005 ·The Journal of Cell Biology ·Daniela Piazzolla, Katrin Meissl, Lucia Kučerová, (unknown), Manuela Baccarini	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact